Anti-obesity Drugs Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Anti-obesity Drugs Market size is expected to grow at an annual average of 5% during 2021-2027. The global market for anti-obesity drugs has been expanding at a significant rate in recent years. An obvious driver is the surge in obesity levels worldwide, and this market is also being driven by a strong pipeline of anti-obesity drugs. Advanced medical research by pharmaceutical companies, medical schools and institutions, and government agencies has also contributed significantly to the growth of the obesity treatment market.

The following segmentation are covered in this report:

By Type

• class III anti-obesity drugs
• class II anti-obesity drugs
• class I anti-obesity drugs

 By Drug Type

• Prescription Drugs
• OTC Drugs

Company Profile

• Arena Pharmaceuticals Inc.
• Alizyme
• Bayer AG
• Bristol-Myers Squibb
• Currax Pharmaceuticals LLC
• Eisai Co. Ltd
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC

Scope of the report

The research study analyses the Anti-obesity Drugs Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Anti-obesity Drugs Market Report

• What was the Anti-obesity Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Anti-obesity Drugs Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.